Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: Similarity to human Barrett's esophagus

Laboratory Investigation

Volumn 84, Issue 6, 2004, Pages 753-765

  Su, Yinghao ^a   Chen, Xiaoxin ^b   Klein, Michael ^a   Fang, Ming ^a   Wang, Su ^b   Yang, Chung S ^b   Goyal, Raj K ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Esophageal adenocarcinoma; Intestinal metaplasia; Phenotype of columnar lined esophagus

Indexed keywords

CELL PROTEIN; CYCLOOXYGENASE 2; CYTOKERATIN 20; CYTOKERATIN 7; MUCIN; MYC PROTEIN; PROTEIN DAS 1; PROTEIN P53; PROTEIN PS2; UNCLASSIFIED DRUG; VILLIN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CELL DIFFERENTIATION; COLUMNAR EPITHELIUM; DYSPLASIA; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSTOMY; ESOPHAGOGASTROSTOMY; ESOPHAGUS BIOPSY; INTESTINE METAPLASIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SQUAMOUS EPITHELIUM;

ADENOCARCINOMA; ANASTOMOSIS, SURGICAL; ANIMALS; BARRETT ESOPHAGUS; DISEASE MODELS, ANIMAL; DUODENUM; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; MALE; METAPLASIA; MUCOUS MEMBRANE; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; STOMACH;

EID: 2642575932     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700079     Document Type: Article

References (40)

1. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996;110:614-621.
2. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-480.
3. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-338.
4. Falk GW. Barrett's esophagus. Gastroenterology 2002;122:1569-1591.
5. Fein M, Peters JH, Chandrasoma P, et al. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998;2:260-268.
6. Miwa K, Sahara H, Segawa M, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996;67:269-274.
7. Pera M, Brito MJ, Poulsom R, et al. Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis 2000;21:1587-1591.
8. Attwood SE, Smyrk TC, DeMeester TR, et al. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992;111:503-510.
9. Pera M, Cardesa A, Bombi JA, et al. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res 1989;49:6803-6808.
10. Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997;18:2265-2270.
11. Chen X, Yang G, Ding WY, et al. An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 1999;20:1801-1808.
12. Oberg S, Lord RV, Peters JH, et al. Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? J Surg Res 2000;91:111-117.
13. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-777.
14. Schlemper RJ. International consensus classification of gastrointestinal epithelial neoplasia: usefulness for esophageal squamous epithelium. In: Imamura M (ed). Superficial Esophageal Neoplasm: Pathology, Diagnosis, and Therapy. Springer-Verlag: Tokyo, Japan, 2002, pp 75-82.
15. Rubio CA. Histocytologic criteria for squamous cell carcinoma in situ of the esophagus. In: Imamura M (ed). Superficial Esophageal Neoplasm: Pathology, Diagnosis, and Therapy. Springer-Verlag: Tokyo, Japan, 2002, pp 113-120.
16. Glickman JN, Chen YY, Wang HH, et al. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 2001;25:569-578.
17. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-993.
18. Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J 1981;13:931-939.
19. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis using the SAS System. SAS Institute, Inc: Cary, NC, 2000.
20. Sheahan DG, Jervis HR. Comparative histochemistry of gastrointestinal mucosubstances. Am J Anat 1976;146:103-131.
21. Ormsby AH, Vaezi MF, Richter JE, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000;119:683-690.
22. Das KM, Prasad I, Garla S, et al. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med 1994;120:753-756.
23. MacLennan AJ, Orringer MB, Beer DG. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. Mol Carcinogen 1999;24:137-143.
24. Glickman JN, Wang H, Das KM, et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol 2001;25:87-94.
25. Poulsom R, Wright NA. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol 1993;265:G205-G213.
26. Shields HM, Rosenberg SJ, Zwas FR, et al. Prospective evaluation of multilayered epithelium in Barrett's esophagus. Am J Gastroenterol 2001;96:3268-3273.
27. Witjes JA, van Balken MR, van de Kaa CA. The prognostic value of a primary inverted papilloma of the urinary tract. J Urol 1997;158:1500-1505.
28. Fein M, Fuchs KH, Stopper H, et al. Duodenogastric reflux and foregut carcinogenesis: analysis of duodenal juice in a rodent model of cancer. Carcinogenesis 2000;21:2079-2084.
29. Jenkins GJ, Harries K, Doak SH, et al. The bile acid deoxycholic acid (DCA) at neutral pH, activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis 2003, Dec 4 [Epub ahead of print].
30. Tselepis C, Morris CD, Wakelin D, et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 2003;52:174-180.
31. Ireland AP, Peters JH, Smyrk TC, et al. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 1996;224:358-370.
32. Kawaura Y, Tatsuzawa Y, Wakabayashi T, et al. Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett's esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model. J Gastroenterol 2001;36:595-600.
33. Warson C, Van De Bovenkamp JH, Korteland-Van Male AM, et al. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol 2002;33:660-668.
34. Boch JA, Shields HM, Antonioli DA, et al. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology 1997:112:760-765.
35. Jankowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet 2000;356:2079-2085.
36. Chen X, Ding YW, Yang G, et al. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000;21:257-263.
37. Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001;22:1119-1129.
38. Chen X, Li N, Wang S, et al. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis 2002;23:2095-2102.
39. Buttar NS, Wang KK, Leontovich O, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002;122:1101-1112.
40. Fein M, Peters JH, Baril N, et al. Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux. J Surg Res 1999;83:48-55.